WallStreetZenWallStreetZen

AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Bottom 2%
#4334 out of 4414 analysts
Average Return
-20.89%
Win Rate
28%7 out of 25
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Pardes Biosciences IncPRDS
+81.51%$1.19$2.16
2022-12-12 -
2023-08-30
Buy
Pardes Biosciences IncPRDS
+60.00%$1.35$2.16
2023-03-14 -
2023-08-30
Buy
Dynavax Technologies CorpDVAX
+36.27%$10.45$14.24
2022-09-26 -
2023-09-26
Buy
Argenx SeARGX
+28.33%$347.02$445.34
2023-03-02 -
2023-11-28
Buy
Dynavax Technologies CorpDVAX
+28.19%$10.36$13.28
2023-02-23 -
2023-11-28
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Enanta Pharmaceuticals IncENTA
6Buy$23.00+136.87%Maintains
9 days ago
Dynavax Technologies CorpDVAX
5Buy$27.00+103.31%Maintains
a month ago
Arbutus Biopharma CorpABUS
3Buy$6.00+224.32%Reiterates
5 months ago
Curevac NvCVAC
4Buy$24.00+336.36%Maintains
7 months ago
Pardes Biosciences IncPRDS
2Buy$5.00+131.48%Maintains
8 months ago
Esperion Therapeutics IncESPR
1Buy$15.00+1,129.51%Reiterates
9 months ago
Argenx SeARGX
2Buy$448.00+0.60%Maintains
9 months ago
Cormedix IncCRMD
1Hold$16.00+376.19%Maintains
9 months ago
Ibio IncIBIO
1Buy$37.50N/AInitiates Coverage On
2 years ago
Polypid LtdPYPD
1Buy$420.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.